Enteroflegin

Enteroflegin is a multicomponent nutraceutical formulation developed by Shedir Pharma, specifically designed for the management of symptomatic uncomplicated diverticular disease (SUDD). The product combines standardized natural active ingredients, including extracts of *Boswellia serrata*, *Curcuma longa* (turmeric), and *Matricaria chamomilla* (chamomile). These botanical components work synergistically to provide anti-inflammatory and antispasmodic effects; *Boswellia* inhibits the 5-lipoxygenase enzyme, *Curcuma* modulates inflammatory mediators like NF-kappaB and COX-2, and *Matricaria* helps alleviate gastrointestinal spasms. Clinical data suggests that Enteroflegin is effective in inducing symptom remission, reducing abdominal pain, and lowering fecal calprotectin levels in patients with SUDD, while also potentially aiding in the prevention of acute diverticulitis.

Brand names

Enteroflegin